Institutional investors hold a majority ownership of AGN through the 87.80% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2017, these large investors purchased a net $16.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VERITAS ASSET MANAGEMENT LLP Bought 3.2 Million shares of Allergan
JENNISON ASSOCIATES LLC Bought 1.6 Million shares of Allergan
GOLDMAN SACHS & CO. LLC (PRIVATE... Bought 1.3 Million shares of Allergan